Tailored radiation may spare breast cancer patients from arm swelling

NCT ID NCT06583655

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study is testing whether giving radiation therapy tailored to each patient's risk level can reduce arm swelling (lymphedema) while still controlling cancer in women with early-stage breast cancer that has spread to a sentinel lymph node. Participants receive either whole breast radiation alone or radiation to the breast plus regional lymph nodes, depending on clinical and genomic risk assessments. The goal is to see if a personalized approach can avoid the need for more extensive surgery and minimize side effects without increasing the chance of cancer returning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Individualized regional node irradiation (radiation therapy)
What this could lead to
If successful, this could lead to a more personalized approach to radiation after breast cancer surgery, reducing arm swelling without compromising cancer control.
What could go wrong
The trial is early and may not show a clear benefit. Radiation can still cause side effects, and the optimal radiation fields remain uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER INVASIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ruijin hospital, Shanghai jiaotong university school of medicine

    Shanghai, China, 200025, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.